Niki BioSolutions, Inc. NIKI
1.70 USD +0.05 (+3.03%)
Regular-session close
1.69 -0.01 -0.59%
After hours · Nov 16, 4:00 PM ET
1.56 Day range 1.70
1.50 52-week range 16.20
- YTD
- -83.96%
- 1 year
- -87.68%
- Market cap
- 5.30M
- EPS (ttm)
- -2.99
- YTD return
- -83.96%
- 1-year return
- -87.68%
- Volume
- 9.58K
- Avg volume
- 98.27K
- Open
- 1.62
- Previous close
- 1.65
- Day's range
- 1.56 – 1.70
- 52-week range
- 1.50 – 16.20
No chart data for this range yet.
Fundamental scorecard
4 of 25 checks passed on NIKI’s reported financials
4of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 2 of 5
- Dividend 0 of 5
Statements to Dec 31, 2025.
Financials — quick view
NIKI Revenue — annual 0
NIKI Net income — annual -1.36M
NIKI EPS — annual -1.90
News
Niki BioSolutions' DiamiR Biosciences To Present Poster At 19th Clinical Trialns On Alzheimer's Disease Conference
Niki BioSolutions Announces Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2026 Conference New York State Department Of Health Provides Clinical Laboratory Evaluation Program Test Approval To Niki BioSolutions' DiamiR Biosciences Subsidiary For Its APOE Genotyping Test
12 Health Care Stocks Moving In Tuesday's After-Market Session
Your note
Sign in to keep a note on NIKI — it syncs with the Stock Master app.
